Effect of subchronic lithium treatment on apomorphine-induced change in prolactin and growth hormone secretion.
D000328:Adult; D001058:Apomorphine / Q000008:administration & dosage*; D001714:Bipolar Disorder / Q000097:blood / Q000188:drug therapy* / Q000523:psychology; D005260:Female; D013006:Growth Hormone / Q000097:blood*; D006801:Humans; D008094:Lithium / Q000627:therapeutic use*; D016651:Lithium Carbonate; D008297:Male; D011388:Prolactin / Q000097:blood*; D011954:Receptors, Dopamine / Q000187:drug effects
D011954:Receptors, Dopamine; D016651:Lithium Carbonate; D011388:Prolactin; D013006:Growth Hormone; D008094:Lithium; D001058:Apomorphine